Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (491-500 of 663) with videos related to

Pageof 67
Sort By:
Plos Pathogens|May 4, 2017
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over timeLina Josefsson, Susanne von Stockenstrom, Nuno R Faria, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Journal of Virology|April 29, 2011
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infectionDevi SenGupta, Ravi Tandon, Raphaella G S Vieira, et al.
Plos Pathogens|March 26, 2016
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
The Lancet. HIV|December 3, 2020
The case for an HIV cure and how to get thereMark Dybul, Timothy Attoye, Solange Baptiste, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
JCI Insight|June 30, 2026
A distinct form of fat fibrosis is linked to insulin resistance in people with HIVDiana L Alba, Alaa Abdellatif, Moon K Choi, et al.
Pageof 67

Showing results (491-500 of 663) with videos related to

Sort By:
Pageof 67
Plos Pathogens|May 4, 2017
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Science (New York, N.Y.)|June 6, 2009
A step ahead on the HIV collaboratoryRobert L Murphy, Brigitte Autran, Christine Katlama, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over timeLina Josefsson, Susanne von Stockenstrom, Nuno R Faria, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Journal of Virology|April 29, 2011
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infectionDevi SenGupta, Ravi Tandon, Raphaella G S Vieira, et al.
Plos Pathogens|March 26, 2016
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialSergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
The Lancet. HIV|December 3, 2020
The case for an HIV cure and how to get thereMark Dybul, Timothy Attoye, Solange Baptiste, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
JCI Insight|June 30, 2026
A distinct form of fat fibrosis is linked to insulin resistance in people with HIVDiana L Alba, Alaa Abdellatif, Moon K Choi, et al.
Pageof 67